# Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects

> **NCT05298332** · PHASE1 · TERMINATED · sponsor: **Antios Therapeutics, Inc** · enrollment: 37 (actual)

## Conditions studied

- Chronic Hepatitis b

## Interventions

- **DRUG:** ATI-2173 50 mg

## Key facts

- **NCT ID:** NCT05298332
- **Lead sponsor:** Antios Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-29
- **Primary completion:** 2022-08-22
- **Final completion:** 2022-08-22
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Terminated by the Sponsor
- **Last updated:** 2022-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05298332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05298332, "Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05298332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*